Skip to Main Content

Author Details

Julie A Johnson
Department of Pharmacotherapy and Translational Research, University of Florida
1992
323
64
PMIDPaper TitleJournal TitlePublished Year
37383676A Pharmacogenetics-Based Approach to Managing Gastroesophageal Reflux Disease: Current Perspectives and Future Steps.Pharmgenomics Pers Med2023
37084734Use of a multi-gene pharmacogenetic panel reduces adverse drug effects.Cell Rep Med2023
34713976β1-receptor polymorphisms and junctional ectopic tachycardia in children after cardiac surgery.Clin Transl Sci2022
35432462Comparison of Data Normalization Strategies for Array-Based MicroRNA Profiling Experiments and Identification and Validation of Circulating MicroRNAs as Endogenous Controls in Hypertension.Front Genet2022
35429163Impact of the ABCD-GENE Score on Clopidogrel Clinical Effectiveness after PCI: A Multi-Site, Real-World Investigation.Clin Pharmacol Ther2022
35488487A randomized, cross-over trial of metoprolol succinate formulations to evaluate PK and PD end points for therapeutic equivalence.Clin Transl Sci2022
35660539Design and rationale of GUARDD-US: A pragmatic, randomized trial of genetic testing for APOL1 and pharmacogenomic predictors of antihypertensive efficacy in patients with hypertension.Contemp Clin Trials2022
35812313Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease: An Individual-Level Meta-Analysis.Front Physiol2022
36597259CYP2D6 pharmacogenetics and phenoconversion in personalized medicine.Expert Opin Drug Metab Toxicol2022
36144188Influence of Genetic West African Ancestry on Metabolomics among Hypertensive Patients.Metabolites2022
36271676Pairwise comparison of hydrochlorothiazide and chlorthalidone responses among hypertensive patients.Clin Transl Sci2022
36240095Contribution of Common Genetic Variants to Risk of Early-Onset Ischemic Stroke.Neurology2022
35886043Genetic Contributors of Efficacy and Adverse Metabolic Effects of Chlorthalidone in African Americans from the Genetics of Hypertension Associated Treatments (GenHAT) Study.Genes (Basel)2022
35156424<i>CYP2C19</i> Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings.J Am Heart Assoc2022
35034351Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update.Clin Pharmacol Ther2022
35108398Warfarin Dosing in Patients With CYP2C9*5 Variant Alleles.Clin Pharmacol Ther2022
32897581Impact of the CYP2C19*17 Allele on Outcomes in Patients Receiving Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.Clin Pharmacol Ther2021
33667324Tribute to Professor Hartmut Derendorf - 1953 to 2020: Driving force in Clinical Pharmacology and Mentor Extraordinaire.Clin Pharmacol Ther2021
33748830Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality.Eur Heart J2021
34564461Metabolomics Signature of Plasma Renin Activity and Linkage with Blood Pressure Response to Beta Blockers and Thiazide Diuretics in Hypertensive European American Patients.Metabolites2021
34075203Determining the potential clinical value of panel-based pharmacogenetic testing in patients with chronic pain or gastroesophageal reflux disease.Pharmacogenomics J2021
34231218Adverse Cardiovascular Outcomes and Antihypertensive Treatment: A Genome-Wide Interaction Meta-Analysis in the International Consortium for Antihypertensive Pharmacogenomics Studies.Clin Pharmacol Ther2021
34231197How to Integrate CYP2D6 Phenoconversion Into Clinical Pharmacogenetics: A Tutorial.Clin Pharmacol Ther2021
34282303Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing.Genet Med2021
34357114Strategies to Integrate Genomic Medicine into Clinical Care: Evidence from the IGNITE Network.J Pers Med2021
33111220Racial disparities in survival outcomes among breast cancer patients by molecular subtypes.Breast Cancer Res Treat2021
33420349A hybrid implementation-effectiveness randomized trial of CYP2D6-guided postoperative pain management.Genet Med2021
32770672Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing.Clin Pharmacol Ther2021
32293069Sorting nexin 1 loss results in increased oxidative stress and hypertension.FASEB J2020
31910286A Scoping Review of the Evidence Behind Cytochrome P450 2D6 Isoenzyme Inhibitor Classifications.Clin Pharmacol Ther2020
31758664Clinical Utility of Pharmacogene Panel-Based Testing in Patients Undergoing Percutaneous Coronary Intervention.Clin Transl Sci2020
31751490The Patient-Centered Future of Clinical Pharmacology.Clin Pharmacol Ther2020
31891170Response to: Heterogeneous Treatment Response by Race Cannot Be Claimed in the Absence of Evidence.Am J Hypertens2020
32042096Cost-effectiveness of CYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention informed by real-world data.Pharmacogenomics J2020
31853537Combination Antihypertensive Therapy Prescribing and Blood Pressure Control in a Real-World Setting.Am J Hypertens2020
31709518Clinical Pharmacology Education - The Decade Ahead.Clin Pharmacol Ther2020
33067866Examination of Metoprolol Pharmacokinetics and Pharmacodynamics Across CYP2D6 Genotype-Derived Activity Scores.CPT Pharmacometrics Syst Pharmacol2020
32747766Correction: Evaluating the extent of reusability of CYP2C19 genotype data among patients genotyped for antiplatelet therapy selection.Genet Med2020
32708920Design and Early Implementation Successes and Challenges of a Pharmacogenetics Consult Clinic.J Clin Med2020
32654539Association of Factor V Leiden With Subsequent Atherothrombotic Events: A GENIUS-CHD Study of Individual Participant Data.Circulation2020
32678355Evaluating the extent of reusability of CYP2C19 genotype data among patients genotyped for antiplatelet therapy selection.Genet Med2020
32726152Pharmacogenetic factors affecting β-blocker metabolism and response.Expert Opin Drug Metab Toxicol2020
32460360How to Transition from Single-Gene Pharmacogenetic Testing to Preemptive Panel-Based Testing: A Tutorial.Clin Pharmacol Ther2020
30406943Essential Characteristics of Pharmacogenomics Study Publications.Clin Pharmacol Ther2019
31754133Genome Wide Analysis Approach Suggests Chromosome 2 Locus to be Associated with Thiazide and Thiazide Like-Diuretics Blood Pressure Response.Sci Rep2019
30237584Genome-wide association analysis of common genetic variants of resistant hypertension.Pharmacogenomics J2019
31532792Hypertensive APOL1 risk allele carriers demonstrate greater blood pressure reduction with angiotensin receptor blockade compared to low risk carriers.PLoS One2019
31327267Gene Variants at Loci Related to Blood Pressure Account for Variation in Response to Antihypertensive Drugs Between Black and White Individuals.Hypertension2019
31368851A case for genotype-guided pain management.Pharmacogenomics2019
31423876Genome-Wide Meta-Analysis of Blood Pressure Response to β<sub>1</sub>-Blockers: Results From ICAPS (International Consortium of Antihypertensive Pharmacogenomics Studies).J Am Heart Assoc2019
  • 1 - 50 of 323

Recommended Authors

Alyson L Dickson
Vanderbilt University Medical Center
Career Start Year 2019
Number of shared co-authors 11
Heidi E Steiner
Data Science Institute, University of Arizona
Career Start Year 2017
Number of shared co-authors 11
Moneeza K Siddiqui
University of Dundee, Ninewells Hospital and Medical School
Career Start Year 2016
Number of shared co-authors 29
Megan M Shuey
Vanderbilt University Medical Center
Career Start Year 2013
Number of shared co-authors 13
Omri Gottesman
Icahn School of Medicine at Mount Sinai
Career Start Year 2011
Number of shared co-authors 118
Jessica Minnier
Louis Stokes Cleveland VA Medical Center Cleveland
Career Start Year 2010
Number of shared co-authors 5
QiPing Feng
Vanderbilt University Medical Center
Career Start Year 2008
Number of shared co-authors 62
James S Floyd
Cardiovascular Health Research Unit, University of Washington
Career Start Year 2008
Number of shared co-authors 69
Nathan E Wineinger
Scripps Research Translational Institute, The Scripps Research Institute
Career Start Year 2008
Number of shared co-authors 12
Quinn S Wells
Vanderbilt University Medical Center
Career Start Year 2008
Number of shared co-authors 88
James Brian Byrd
University of Michigan School of Medicine ann arbor
Career Start Year 2006
Number of shared co-authors 5
Thomas J Urban
Eshelman School of Pharmacy, University of North Carolina
Career Start Year 2003
Number of shared co-authors 4
Dongliang Ge
Department of Pharmacy, Liyang People's Hospital
Career Start Year 2003
Number of shared co-authors 8
Alex S F Doney
University of Dundee. Ninewells Hospital
Career Start Year 2002
Number of shared co-authors 106
Sook Wah Yee
University of California San Francisco
Career Start Year 2001
Number of shared co-authors 38
Xin-Qun Wang
University of Virginia Health System
Career Start Year 2001
Number of shared co-authors 13
Jeanette J McCarthy
Fabric Genomics Inc.
Career Start Year 2000
Number of shared co-authors 7
Linnea M Baudhuin
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 13
Lara M Mangravite
Children's Hospital Oakland Research Institute
Career Start Year 1998
Number of shared co-authors 18
Thomas J Wang
Vanderbilt University
Career Start Year 1998
Number of shared co-authors 79
Brinda K Rana
University of California
Career Start Year 1996
Number of shared co-authors 3
Carsten Skarke
University of Pennsylvania.
Career Start Year 1995
Number of shared co-authors 6
Jonathan D Mosley
Vanderbilt University Medical Center
Career Start Year 1995
Number of shared co-authors 53
Sheldon W Tobe
University of Toronto, Canada Northern Ontario School of Medicine
Career Start Year 1991
Number of shared co-authors 2
Bruce C Carleton
BC Children's Hospital Research Institute
Career Start Year 1991
Number of shared co-authors 15
Vincent Mooser
McGill University
Career Start Year 1987
Number of shared co-authors 82
Mark A Munger
Department of Pharmacotherapy, University of Utah Health
Career Start Year 1986
Number of shared co-authors 2
Bryan Williams
Institute of Cardiovascular Sciences, University College London.
Career Start Year 1982
Number of shared co-authors 5
Philip T Sager
Inc., Canada Cardiovascular Research Institute, Stanford University
Career Start Year 1975
Number of shared co-authors 10
Alastair J J Wood
Vanderbilt University
Career Start Year 1974
Number of shared co-authors 3

Collaborators

Rhonda M Cooper-DeHoff
College of Medicine, University of Florida
Co-authored papers 106
Taimour Y Langaee
Center for Pharmacogenomics and Precision Medicine, University of Florida
Co-authored papers 77
Amber L Beitelshees
University of Maryland School of Medicine
Co-authored papers 74
Stephen T Turner
Mayo Clinic
Co-authored papers 62
Eric Boerwinkle
Baylor College of Medicine
Co-authored papers 55
Larisa H Cavallari
Department of Pharmacotherapy and Translational Research, University of Florida
Co-authored papers 54
Caitrin W McDonough
Department of Pharmacotherapy and Translational Research, University of Florida
Co-authored papers 53
Kent R Bailey
Mayo Clinic
Co-authored papers 34
Teri E Klein
Stanford University
Co-authored papers 24
Alan R Shuldiner
University of Maryland School of Medicine
Co-authored papers 20
Nita A Limdi
Heersink School of Medicine, University of Alabama at Birmingham
Co-authored papers 20
Dan M Roden
Vanderbilt University Medical Center
Co-authored papers 19
Nihal El Rouby
Department of Pharmacy Practice and Administrative Sciences, University of Cincinnati
Co-authored papers 19
Russ B Altman
Stanford University
Co-authored papers 18
Amanda R Elsey
Department of Pharmacotherapy and Translational Research, University of Florida
Co-authored papers 16
Kristin W Weitzel
Department of Pharmacotherapy & Translational Research, University of Florida
Co-authored papers 14
Wolfgang Sad??e
College of Medicine, The Ohio State University
Co-authored papers 13
Ben Burkley
University of Florida College of Pharmacy Center for Pharmacogenomics
Co-authored papers 11
Stuart A Scott
Stanford University
Co-authored papers 11
Stephen E Kimmel
University of Florida
Co-authored papers 11
Mary V Relling
Departments of Pharmaceutical Sciences.
Co-authored papers 10
Josh F Peterson
Vanderbilt University Medical Center
Co-authored papers 9
Braxton D Mitchell
Co-authored papers 9
Sony Tuteja
University of Pennsylvania Perelman School of Medicine
Co-authored papers 8
Emily J Cicali
Department of Pharmacotherapy and Translational Research, University of Florida
Co-authored papers 8
Joshua C Denny
Vanderbilt University
Co-authored papers 8
Howard L McLeod
Center for Precision Medicine and Functional Genomics, Utah Tech University
Co-authored papers 8
Michael J Clare-Salzler
University of Florida College of Medicine
Co-authored papers 8
Nicholas J Schork
University of California San Diego
Co-authored papers 8
Donald M Smith
Georgetown University Medical Center
Co-authored papers 8
Release 1.2